Company Analysis

Mangoceuticals, Inc. (MGRX)

Nasdaq: MGRX · Services-Misc Health & Allied Services, NEC · Dallas, TX · filing with the SEC since 2022
Grade2.9
◀ Past 2.4● Present 3.1▶ Future 3.2
2 est.

Who runs Mangoceuticals, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Cohen Jacob D.
Chief Executive Officer. First filing Mar 2023, latest Oct 6, 2026, 0 filings in all.
Officers reporting now
2
of 5 people with a filing in the last fifteen months
Directors reporting now
3
8 people on the record since 2023
Officerssales are open-market, Oct 6, 2025 to Oct 6, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Cohen Jacob D.Chief Executive OfficerMar 2023Oct 6, 2026none
Johnston Eugene MCFOMar 2023Oct 6, 20263 · $0.00
Directorssales are open-market, Oct 6, 2025 to Oct 6, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hamilton Alex P.directorMar 2023Oct 6, 20261 · $200,000
D'Alessio Lorraine PameladirectorMar 2023Sep 12, 2025none
Myers KennydirectorMar 2023Sep 12, 2025none
Owners of more than 10% of a classsales are open-market, Oct 6, 2025 to Oct 6, 2026
NameRoleFirst filingLatest filingSales, 12 months
Tiger Cub Trust10% ownerApr 2023Oct 6, 2026none
Earlier names on the record3, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton MGRX · research, not advice